{"url_path":"/sec/hae/8-k/2026-06-05/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-05","source_url":"https://www.sec.gov/Archives/edgar/data/313143/0000313143-26-000057-index.html","accession_number":"0000313143-26-000057","cik":"0000313143","ticker":"HAE","issuer_name":"HAEMONETICS CORP","edgar_url":"https://www.sec.gov/Archives/edgar/data/313143/0000313143-26-000057-index.html","primary_entity_key":"0000313143","primary_entity_name":"HAEMONETICS CORP"},"word_count":81,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d)    Exhibits\n\nExhibit NumberDescription\n\n[99.1](ex991-pressrelease652026.htm)\nPress Release issued by Haemonetics Corporation on June 5, 2026.\n\n104Cover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\nHAEMONETICS CORPORATION\n\nJune 5, 2026By:/s/ Christopher A. Simon\n\nName:Christopher A. Simon\n\nTitle:President and Chief Executive Officer"}